Europe Cell Line Development Market is expected to reach US$ 3,187.57 million by 2027

Recombinant Cell Line Segment Held Largest Share of Type in Europe Cell Line Development Market in 2019

According to The Insight Partners market research study of ‘Europe cell line development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by type, product, and application’ the Europe cell line development market is expected to reach US$ 3,187.57 million in 2027 from US$ 1,214.01 million in 2019. The market is estimated to grow with a CAGR of 13.0% from 2020-2027. The report provides trends prevailing in the Europe cell line development market and the factors driving market along with those that act as hindrances.

Based on type, the cell line development market is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell line. The recombinant cell line segment held the largest share of the market in 2019, whereas the hybridomas segment is anticipated to register the highest CAGR in the market during the forecast period. The recombinant cell line segment's growth is fuelled due to the rising demand for recombinant proteins, increasing use of recombinant cell lines for bio therapeutics and growing demand for toxicity testing. Additionally, the hybridomas segments growth is expected to grow at the fastest CAGR during the forecast period due to the increasing demand for production of monoclonal antibodies and rising research and development expenditure of pharmaceutical and biotechnology companies.

The growth of this market is estimated to grow owing to key driving factors such as the increasing government participation in the cell line development market and an upsurge in the development of the biotechnology industry. However, the market growth is likely to be hindered owing to the contamination of the cell line by microorganisms.

WuXi AppTec, Merck KGaA , and Lonza are among the leading companies operating in the Europe cell line development market. 

The report segments Europe Cell Line Development Market as Follows:

By Type

• Primary Cell Line
• Hybridomas
• Continuous Cell Lines
• Recombinant Cell Line

By Product

• Equipment
• Media & Reagent

By Application

• Drug Discovery
• Bioproduction
• Tissue Engineering

By Country

• Europe

• • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe